TLR7 imidazoquinoline ligand 3M-019 is a potent adjuvant for pure protein prototype vaccines Dean JohnstonBushra ZaidiJean-Claude Bystryn Original Article 01 December 2006 Pages: 1133 - 1141
Targeting tumour cells with defects in the MHC Class I antigen processing pathway with CD8+ T cells specific for hydrophobic TAP- and Tapasin-independent peptides: the requirement for directed access into the ER Farah AladinGeorg LautschamNeil Blake Original Article 02 December 2006 Pages: 1143 - 1152
NK cells rapidly remove B16F10 tumor cells in a perforin and interferon-gamma independent manner in vivo Martin A. GrundyTong ZhangCharles L. Sentman Original Article 08 December 2006 Pages: 1153 - 1161
[F-18]-Fluoro-2-deoxy-d-glucose positron emission tomography as a tool for early detection of immunotherapy response in a murine B cell lymphoma model Coralie ChaiseEmmanuel IttiValérie Molinier-Frenkel Original Article 14 December 2006 Pages: 1163 - 1171
Overexpression of B7-H1 (PD-L1) significantly associates with tumor grade and postoperative prognosis in human urothelial cancers Juro NakanishiYoshihiro WadaShoichi Ueda Original Article 22 December 2006 Pages: 1173 - 1182
Assessment of CD4+ T cells specific for the tumor antigen SSX-1 in cancer-free individuals Emmanuelle GodefroyYu WangMaha Ayyoub Original Article 22 December 2006 Pages: 1183 - 1192
An MVA vaccine overcomes tolerance to human p53 in mice and humans Guang-Yun SongGlen GibsonJoshua D. I. Ellenhorn Original Article 12 January 2007 Pages: 1193 - 1205
Efficacy of an osmotic pump delivered, GM-CSF-based tumor vaccine in the treatment of upper aerodigestive squamous cell carcinoma in rats Hamid R. DjalilianEmiro CaicedoFrank G. Ondrey Original Article 12 January 2007 Pages: 1207 - 1214
Monoclonal antibody 2C5-modified doxorubicin-loaded liposomes with significantly enhanced therapeutic activity against intracranial human brain U-87 MG tumor xenografts in nude mice Bhawna GuptaVladimir P. Torchilin Original Article 12 January 2007 Pages: 1215 - 1223
The C-type lectin MGL expressed by dendritic cells detects glycan changes on MUC1 in colon carcinoma Eirikur SaelandSandra J. van VlietYvette van Kooyk Original Article 29 December 2006 Pages: 1225 - 1236
Tumor cells prevent mouse dendritic cell maturation induced by TLR ligands Juliana IdoyagaJosé MorenoLaura Bonifaz Original Article 20 January 2007 Pages: 1237 - 1250
Encapsulation in liposomal nanoparticles enhances the immunostimulatory, adjuvant and anti-tumor activity of subcutaneously administered CpG ODN Susan de JongGhania ChikhYing Tam Original Article 23 January 2007 Pages: 1251 - 1264
Mechanism of antitumor effect on mouse hepatocellular carcinoma by intratumoral injection of OK-432, a streptococcal preparation Sadamu HommaYukiko SagawaMasato Okamoto Original Article 12 January 2007 Pages: 1265 - 1274
Prevention of human PC-346C prostate cancer growth in mice by a xenogeneic tissue vaccine Mark A. SuckowElliot D. RosenMartin Tenniswood Original Article 23 January 2007 Pages: 1275 - 1283
Chemotherapy and zoledronate sensitize solid tumour cells to Vγ9Vδ2 T cell cytotoxicity Stephen R. MattarolloTony KennaAndrew J. Nicol Original Article 31 January 2007 Pages: 1285 - 1297
Evaluation of a xenogeneic VEGF vaccine in dogs with soft tissue sarcoma Debra KamstockRobyn ElmslieSteven Dow Original Article 14 February 2007 Pages: 1299 - 1309
International conference: progress in vaccination against cancer-2006 (PIVAC 6), Granada, Spain Natalia AptsiauriTeresa CabreraAngel Garcia-Lora Meeting Report 21 March 2007 Pages: 1311 - 1322